glp 1 and inflammation reduction GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, Emerging Therapies Anti-Inflammatory Effects of GLP-1 Receptor
Description
GLP-1 receptor agonists are a novel class of pharmacological agents for obesity and T2D
The molecular mechanism by which GLP-1 protects MG-induced beta cell apoptosis remains unclear
In Prepared Foods, Lea Ben-Akiva discusses how GLP-1 medications like Ozempic and Wegovy are reshaping consumer food choices
Low-cost GLP-1
The recently initiated large-sized FLOW trial investigating the effects of semaglutide on hard renal outcomes in patients with DKD will provide clarity whether GLP-1 receptor agonists may reduce the burden of DKD in addition to their other beneficial metabolic and cardiovascular effects.
